Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccinia”

194 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 194 results

Early research (Phase 1)Study completedNCT05762523
What this trial is testing

Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years

Who this might be right for
SmallpoxMonkeypoxCowpox+1 more
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 60
Large-scale testing (Phase 3)Study completedNCT01913353
What this trial is testing

A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®

Who this might be right for
18-42 Year Old Healthy Vaccinia-naïve Subjects
Bavarian Nordic 440
Early research (Phase 1)Study completedNCT00574977
What this trial is testing

Safety Study of Modified Vaccinia Virus to Cancer

Who this might be right for
MelanomaBreast CancerHead and Neck Squamous Cell Cancer+3 more
David Bartlett 26
Early research (Phase 1)Study completedNCT01766739
What this trial is testing

Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 18
Very early researchStudy completedNCT07302945
What this trial is testing

A Single-volunteer Study of Immune Response Following OTS-412 Vaccinia Virus Systemic Injection(Self-experiment)

Who this might be right for
Healthy Volunteer
Bionoxx Inc. 1
Testing effectiveness (Phase 2)WithdrawnNCT00227474
What this trial is testing

S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission

Who this might be right for
Breast Cancer
SWOG Cancer Research Network
Early research (Phase 1)Study completedNCT00079820
What this trial is testing

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

Who this might be right for
Smallpox
Sanofi Pasteur, a Sanofi Company 110
Testing effectiveness (Phase 2)Study completedNCT02598388
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 578
Early research (Phase 1)Study completedNCT01147991
What this trial is testing

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

Who this might be right for
Gastric CancerHead and Neck CancerLymphoma+2 more
Cancer Research UK 16
Early research (Phase 1)Study completedNCT00001043
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00000683
What this trial is testing

A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Study completedNCT00428337
What this trial is testing

Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00002261
What this trial is testing

A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00429312
What this trial is testing

Recombinant Vaccinia Virus to Treat Malignant Melanoma

Who this might be right for
Melanoma
Jennerex Biotherapeutics 10
Early research (Phase 1)Study completedNCT00423839
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers

Who this might be right for
Tuberculosis
University of Oxford 12
Testing effectiveness (Phase 2)Ended earlyNCT01329809
What this trial is testing

Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors

Who this might be right for
Colorectal Carcinoma
Jennerex Biotherapeutics 2
Not applicableLooking for participantsNCT06616753
What this trial is testing

Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital

Who this might be right for
Vaccinia
Groupe Hospitalier Sud Ile-de-France 140
Early research (Phase 1)Study completedNCT03615911
What this trial is testing

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

Who this might be right for
MERS (Middle East Respiratory Syndrome)
Marylyn Addo 26
Testing effectiveness (Phase 2)Study completedNCT00116597
What this trial is testing

Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma

Who this might be right for
Melanoma
University Hospital, Basel, Switzerland 15
Testing effectiveness (Phase 2)Study completedNCT00081835
What this trial is testing

Evaluation and Treatment of Eye Complications of Vaccinia Vaccination

Who this might be right for
Vaccinia
National Eye Institute (NEI) 400
Load More Results